Literature DB >> 12237176

The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta.

Andrew J Wilson1, Lucie H Clapp.   

Abstract

OBJECTIVE: ATP-sensitive potassium (K(ATP)) channels are important modulators of vascular tone. Abnormal activation of these channels via over production of nitric oxide (NO) has been implicated in endotoxin-induced hypotension. However, based on studies with the sulphonylurea K(ATP) channel inhibitor, glibenclamide, there is little evidence to support their role in mediating vasorelaxation to endotoxin in isolated blood vessels. In the present study, we investigated whether NO derived from inducible NO synthase (iNOS) modulates K(ATP) channel function in rat aorta.
METHODS: Using standard organ bath techniques, the effects of structurally unrelated K(ATP) channel inhibitors on the vasorelaxant responses to L-arginine (iNOS substrate), NO, levcromakalim (K(ATP) channel opener) and forskolin were investigated in endothelium-denuded aortic rings exposed to endotoxin (lipopolysaccharide) for 4 h.
RESULTS: Relaxation evoked by L-arginine was unaffected by glibenclamide and the pinacidil-derived inhibitor, PNU-99963, but was significantly attenuated by the iNOS inhibitor, 1400W, as well as by PNU-37883A, Ba2+, 4-aminopyridine and tetraethylammonium, all known inhibitors of the K(ATP) channel pore. In addition, endotoxin potentiated responses to levcromakalim and markedly reduced the efficacy of glibenclamide, and to a much lesser extent, PNU-37883A. Forskolin responses were unaffected by glibenclamide or PNU-37883A under control conditions, but were significantly potentiated following endotoxin treatment, an effect reversed by PNU-37883A, but not glibenclamide.
CONCLUSION: K(ATP) channels contribute to iNOS-mediated relaxation. However, the ability of sulphonylurea receptor-binding agents, but not those binding directly to the pore, to inhibit K(ATP) channels, is greatly diminished in the presence of endotoxin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237176     DOI: 10.1016/s0008-6363(02)00504-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  HMR1402, a potassium ATP channel blocker during hyperdynamic porcine endotoxemia: effects on hepato-splanchnic oxygen exchange and metabolism.

Authors:  Pierre Asfar; Zsolt Iványi; Hendrik Bracht; Balázs Hauser; Antje Pittner; Damian Vassilev; Marek Nalos; Xavier Maurice Leverve; Uwe Bernd Brückner; Peter Radermacher; Gebhard Fröba
Journal:  Intensive Care Med       Date:  2004-03-26       Impact factor: 17.440

2.  The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro.

Authors:  Alastair J O'Brien; Gita Thakur; James F Buckley; Mervyn Singer; Lucie H Clapp
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Vascular ATP-sensitive potassium channels are over-expressed and partially regulated by nitric oxide in experimental septic shock.

Authors:  Solène Collin; Nacira Sennoun; Anne-Gaëlle Dron; Mathilde de la Bourdonnaye; Chantal Montemont; Pierre Asfar; Patrick Lacolley; Ferhat Meziani; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-03-03       Impact factor: 17.440

4.  Ca2+/calcineurin regulation of cloned vascular K ATP channels: crosstalk with the protein kinase A pathway.

Authors:  N N Orie; A M Thomas; B A Perrino; A Tinker; L H Clapp
Journal:  Br J Pharmacol       Date:  2009-05-07       Impact factor: 8.739

5.  Role of ATP-sensitive potassium channels on hypoxic pulmonary vasoconstriction in endotoxemia.

Authors:  Maurizio Turzo; Julian Vaith; Felix Lasitschka; Markus A Weigand; Cornelius J Busch
Journal:  Respir Res       Date:  2018-02-13

6.  Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway.

Authors:  Dan Wu; Qingxun Hu; Fenfen Ma; Yi Zhun Zhu
Journal:  Oxid Med Cell Longev       Date:  2015-11-09       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.